Life Technologies Corporation has announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical ...
Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access ...
Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world’s first Laser PCR instrument based on the company’s proprietary Pulse Controlled Amplification (PCA) technology at the Analytica trade ...
If you’ve ever wished your genetic analyzer could work more like your smartphone, you may be in luck: Thermo Fisher Scientific is bringing high-tech upgrades to its real-time PCR instruments it says ...
The polymerase chain reaction (PCR), invented about three decades ago, soon entered mainstream use thanks to an ongoing series of refinements. One particularly important refinement, introduced about ...
The Pharos V8 is based on the company’s patented Pulse Controlled Amplification (PCA) technology. Conventional PCR platforms rely on thermocyclers that the firm said can limit reaction speed. PCA uses ...
The Pharos V8 is a laser PCR (polymerase chain reaction) instrument powered by pulse-controlled amplification (PCA) technology. It features ultrafast nucleic acid amplification and microcyclers that ...
Vancouver, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size was USD 8.50 Billion in 2022 and is expected to register a revenue CAGR of 8.5% during the forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results